Effect of different treatments on macrophage differentiation in chronic obstructive pulmonary disease and repeated pulmonary infection
Authors:
Open Access
- 1 August 2020
- journal article
- research article
- Published by Elsevier in Saudi Journal of Biological Sciences
- Vol. 27 (8) , 2076-2081
Abstract
No abstract availableKeywords
Funding Information
- Research Project of Health and Family Planning Industry in Hainan Province (18A200002)
- Scientific Research Projects of Higher Education Institutions in Hainan Province (Hnky 2018-50)
This publication has 11 references indexed in Scilit:
- Interleukin 12/interleukin 23 pathway: Biological basis and therapeutic effect in patients with Crohn's diseaseWorld Journal of Gastroenterology, 2018
- Therapeutic effect of ulinastatin on pulmonary fibrosis via downregulation of TGF‑β1, TNF‑α and NF‑κBMolecular Medicine Reports, 2017
- Ulinastatin inhibited sepsis‐induced spinal inflammation to alleviate peripheral neuromuscular dysfunction in an experimental rat model of neuromyopathyJournal of Neurochemistry, 2017
- Protective effect of ulinastatin on severe pulmonary infection under immunosuppression and its molecular mechanismExperimental and Therapeutic Medicine, 2017
- Squamous differentiation in patients with superficial bladder urothelial carcinoma is associated with high risk of recurrence and poor survivalBMC Cancer, 2017
- Down-regulation of CD73 on B cells of patients with viremic HIV correlates with B cell activation and disease progressionJournal of Leukocyte Biology, 2017
- Effects of Emulsified Sevoflurane and Ulinastatin on Liver and Lung Injury Induced by Bile Duct Ligation in RatsJournal of Anesthesia and Perioperative Medicine, 2017
- Ulinastatin post-treatment attenuates lipopolysaccharide-induced acute lung injury in rats and human alveolar epithelial cellsInternational Journal of Molecular Medicine, 2016
- Effects of ulinastatin on early postoperative cognitive function after one-lung ventilation surgery in elderly patients receiving neoadjuvant chemotherapyMetabolic Brain Disease, 2016
- Ulinastatin – a newer potential therapeutic option for multiple organ dysfunction syndromeJournal of Basic and Clinical Physiology and Pharmacology, 2015